13 /100
LOW RISK
Score updated May 29, 2026

NPCE — NeuroPace, Inc. Dilution Risk Tracker

Track NPCE dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track NPCE — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
25
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for NPCE.
🔔 Track NPCE — Get forecast alerts →

💹 Market Data

Market Cap$592.89M
Shares Outstanding34.09M
Float23.36M
Cash$53.98M
Debt$70.46M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 1.8% shares (2025Q4 vs prior)
100 institutional holders · 26.55M shares
#1 Polar Capital Holdings Plc 2.88M shares
#2 Soleus Capital Management, L.P. 2.70M shares
#3 MORGAN STANLEY 2.55M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest773.8K
Days to Cover4.7
% of Float3.3%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2022
xbrl XBRL CONVERTIBLE Dec 31, 2021
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track NPCE Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking NPCE — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for NPCE
📊 NPCE FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 NPCE Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.